Back
Insmed 10K Form
Buy
52
INSM
Insmed
Last Price:
$77.03
Seasonality Move:
34.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | INSM/Insmed Quarterly |
| 2023-10-26 | 10Q | INSM/Insmed Quarterly |
| 2023-08-03 | 10Q | INSM/Insmed Quarterly |
| 2023-05-04 | 10Q | INSM/Insmed Quarterly |
| 2022-10-27 | 10Q | INSM/Insmed Quarterly |
| 2022-08-04 | 10Q | INSM/Insmed Quarterly |
Receive INSM News And Ratings
See the #1 stock for the next 7 days that we like better than INSM
INSM Financial Statistics
Sales & Book Value
| Annual Sales: | $363.7M |
|---|---|
| Cash Flow: | $-202.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.59 |
| Price / Book: | 49.33 |
Profitability
| EPS (TTM): | -5.59000 |
|---|---|
| Net Income (TTM): | $-913.8M |
| Gross Margin: | $278M |
| Return on Equity: | -41989.34% |
| Return on Assets: | -54.54% |
Insmed Earnings Forecast
Key Insmed Financial Ratios
-
The Gross Profit Margin over the past 26 years for INSM is 76.43%.
-
The Selling, General & Administrative Expenses for INSM have been equal to 126.78% of Gross Profit Margin.
-
The Research & Development expenses have been 164.52% of Revenue.
-
The Net Earning history of INSM is -251.24% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 9 years.
Insmed Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INSM |
| CUSIP: | 457669 |
| Website: | insmed.com |
Debt
| Debt-to-Equity Ratio: | 3.87 |
|---|---|
| Current Ratio: | 5.45 |
| Quick Ratio: | 4.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |